Drug Price Negotiations | sciencenewsnet.in

Breaking News

History of COVID-19 Doubles Long-term Risk of Heart Attack, Stroke and Death

Top experts unite at University of Bristol to tackle gambling harms globally

The pitfalls of passion: How it can backfire at work—and what managers can do about it

Largest-Ever Diabetes and Metabolism Research Center Retreat Tackles Problems from Public Health to Drug Development

Harnessing the power of social networks to address the burden of stroke recurrence

Virtual reality separates the wood from the trees in forestry industry

UC Irvine Expert Jun Wu: Ready to comment on EPA’s landmark move to replace all U.S. lead pipes

Argonne receives funding for artificial intelligence in scientific research

Diplomacy needed to deescalate war between Israel and Iran’s proxies, expert explains 

How ghost stories came to haunt Halloween, expert explains

09 Oct, 2024

Cracking the Code on Medicare’s Drug Price Negotiations

October 1, 2024 sarah JonasAnnouncement

ISPOR announced the publication of a study that provides estimates of how the Centers for Medicare & Medicaid Services (CMS) may have determined initial price offers for the first 10 drugs selected for Medicare price negotiation.